ROBERT ESPY: Open Payments
NPI 1205130499 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 54 payments from 16 companies in 2025. Trend: 2023 $475 · 2024 $618 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 19 | $167 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Amgen Inc. | 6 | $101 |
| Otsuka America Pharmaceutical, Inc. | 5 | $77 |
| Medtronic, Inc. | 1 | $59 |
| Inspire Medical Systems, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: AIRSUPRA, MOUNJARO, REXULTI, JARDIANCE, EVENITY, SYMPLICITY G3, INSPIRE, FARXIGA.
Industry payments across AL — which companies pay providers there.
